993
Views
1
CrossRef citations to date
0
Altmetric
Articles; Medical Biotechnology

Impact of IL-10 and IL-12B single nucleotide polymorphisms on circulating cytokine level in development of Hashimoto's thyroiditis

, &
Pages 713-720 | Received 27 Oct 2015, Accepted 30 Mar 2016, Published online: 21 Apr 2016

References

  • Weetman AP. Immunopathogenesis of autoimmune thyroiditis. Eur Thyroid J. 2012;1:243–250.
  • Ajjan RA, Weetman AP. Cytokines in thyroid autoimmunity. Autoimmunity. 2003;36:351–359.
  • Ganesh BB, Bhattacharya P, Gopisetty A, et al. Role of cytokines in the pathogenesis and suppression of thyroid autoimmunity. J Interferon Cytokine Res. 2011;31:721–731.
  • Cogni G, Chiovato L. An overview of the pathogenesis of thyroid autoimmunity. Hormones. 2013;12:19–29.
  • Hackett TL, Holloway R, Holgate ST, et al. Dynamics of pro-inflammatory and anti-inflammatory cytokine release during acute inflammation in chronic obstructive pulmonary disease: an ex vivo study. Respiratory Res [Internet]. 2008 [cited 2016 Jan 13];9:47. Available from: http://dx.doi.org/10.1186/1465-9921-9-47
  • Trinchieri G, Pflanz S, Kastelein RA. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity. 2003;19:641–644.
  • Gately MK, Desai BB, Wolitzky AG, et al. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J Immunol. 1991;147:874–882.
  • Gerenova J, Manolova I, Gadjeva V. Hashimoto's disease – involvement of cytokine network and role of oxidative stress in the severity of Hashimoto's thyroiditis. In: Springer D, editor. A new look at hypothyroidism. Rijeka: InTech; 2012. p. 91–124.
  • Phenekos C, Vryonidou A, Gritzapis AD, et al. Th1 and Th2 serum cytokine profile characterize patients with Hashimoto's thyroiditis (Th1) and Graves’ disease (Th2). Neuroimmunomodulation. 2004;11:209–213.
  • de Waal Malefyt R, Yssel H, de Vries JE. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol. 1993;150:4754–4765.
  • Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med. 1989;170:2081–2095.
  • Ding L, Linsley PS, Huang LY, et al. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol. 1993;51:1224–1234.
  • Rousset F, Garcia E, Defrance T, et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA. 1992;89:1890–1893.
  • Nielsen CH, Hegedüs L, Rieneck K, et al. Production of interleukin (IL)-5 and IL-10 accompanies T helper cell type 1 (Th1) cytokine responses to a major thyroid self-antigen, thyroglobulin, in health and autoimmune thyroid disease. Clin Exp Immunol. 2007;147:287–295.
  • Kristensen B, Hegedüs L, Lundy SK, et al. Characterization of regulatory B cells in Graves' disease and Hashimoto's thyroiditis. PLoS One [Internet]. 2015 [cited 2016 Jan 13];10(5):e0127949. Available from: http://dx.doi.org/10.1371/journal.pone.0127949
  • Yu Z, Liu T, Liu S, et al. Interleukin 10 influences susceptibility to experimental autoimmune thyroiditis independently of the H-2 gene. Int J Mol Med. 2015;35:413–424.
  • Hall MA, McGlinn E, Coakley G, et al. Genetic polymorphism of IL-12 p40 gene in immune-mediated disease. Genes Immun. 2000;1:219–224.
  • Morahan G, Huang D, Ymer SI, et al. Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele. Nat Genet. 2001;27:218–221.
  • Seegers D, Zwiers A, Strober W, et al. A TaqI polymorphism in the 3’UTR of the IL-12 p40 gene correlates with increased IL-12 secretion. Genes Immun. 2002;3:419–423.
  • Stanilova S, Miteva L. Taq-I polymorphism in 3’UTR of the IL-12B and association with IL-12p40 production from human PBMC. Genes Immun. 2005;6:364–366.
  • Karimabad MN, Arababadi MK, Hakimizadeh E, et al. Is the IL-10 promoter polymorphism at position-592 associated with immune system-related diseases? Inflammation. 2013;36:35–41.
  • Westendorp RG, Langermans JA, Huizinga TW, et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet. 1997;349:170–173.
  • Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol. 2003;3:133–146.
  • Zhang JA, Zhang J, Xu L, et al. Measurement of IL-12 and IL-18 in sera of patients with autoimmune thyroid disease. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2006;22:630–632.
  • Guclu F, Ozmen B, Kirmaz C, et al. Down-regulation of the auto-aggressive processes in patients with hypothyroid Hashimoto's thyroiditis following substitutive treatment with L-thyroxine. Eur Cytokine Netw. 2009;20:27–32.
  • Bonita RE, Rose NR, Rasooly L, et al. Kinetics of mononuclear cell infiltration and cytokine expression in iodine-induced thyroiditis in the NOD-H2h4 mouse. Exp Mol Pathol. 2003;74:1–12.
  • Kimura H, Tzou SC, Rocchi R, et al. Interleukin (IL)-12-driven primary hypothyroidism: the contrasting roles of two Th1 cytokines (IL-12 and interferon –γ). Endocrinology. 2005;146:3642–3651.
  • Hunt PJ, Marshall SE, Weetman AP, et al. Cytokine gene polymorphisms in autoimmune thyroid disease. J Clin Endocrinol Metab. 2000;85:1984–1988.
  • Ikeda Y, Yoshida W, Noguchi T, et al. Lack of association between IL-12B gene polymorphism and autoimmune thyroid disease in Japanese patients. Endocr J. 2004;51:609–613.
  • Yang JM, Nagasaka S, Yatagai T, et al. Interleukin-12p40 gene (IL-12B) polymorphism and Type 1 diabetes mellitus in Japanese: possible role in subjects without having high-risk HLA haplotypes. Diabetes Res Clin Pract. 2006;71:164–169.
  • Takeoka K, Watanabe M, Matsuzuka F, et al. Increase of serum interleukin-10 in intractable Graves' disease. Thyroid. 2004;14:201–205.
  • Baki M, Akman FE, Vural P, et al. The combination of interleukin-10 −1082 and tumor necrosis factor α −308 or interleukin-6 −174 genes polymorphisms suggests an association with susceptibility to Hashimoto's thyroiditis. Int Immunopharmacol. 2012;4:543–546.
  • Inoue N, Watanabe M, Wada M, et al. IL-10 −592 A/C polymorphism is associated with severity of Hashimoto's disease. Cytokine. 2013;64:370–374.